Pompe Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2035

Pompe Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2035

Report Format: PDF+Excel | Report ID: SR112025A29175

1 Preface
2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Pompe Disease - Introduction

4.1 Overview
4.2 Regulatory Process
4.3 Epidemiology (​2019-2024​) and Forecast (​2025-2035​)
4.4 Market Overview (​2019-2024​) and Forecast (​2025-2035​)
4.5 Competitive Intelligence
5 Pompe Disease - Disease Overview
5.1 Introduction
5.2 Symptoms and Diagnosis
5.3 Pathophysiology
5.4 Causes and Risk Factors
5.5 Treatment
6 Patient Journey
7 Pompe Disease - Epidemiology and Patient Population

7.1 Epidemiology - Key Insights
7.2 Epidemiology Scenario - Top 7 Markets
7.2.1 Epidemiology Scenario (​2019-2024​)
7.2.2 Epidemiology Forecast (​2025-2035​)
7.2.3 Epidemiology by Age (​​2019-2035​)
7.2.4 Epidemiology by Gender (​​2019-2035​)
7.2.5 Diagnosed Cases (​​2019-2035​)
7.2.6 Patient Pool/Treated Cases (​​2019-2035​)
7.3 Epidemiology Scenario - United States
7.3.1 Epidemiology Scenario (​2019-2024​)
7.3.2 Epidemiology Forecast (​2025-2035​)
7.3.3 Epidemiology by Age (​​2019-2035​)
7.3.4 Epidemiology by Gender (​​2019-2035​)
7.3.5 Diagnosed Cases (​​2019-2035​)
7.3.6 Patient Pool/Treated Cases (​​2019-2035​)
7.4 Epidemiology Scenario - Germany
7.4.1 Epidemiology Scenario (​2019-2024​)
7.4.2 Epidemiology Forecast (​2025-2035​)
7.4.3 Epidemiology by Age (​​2019-2035​)
7.4.4 Epidemiology by Gender (​​2019-2035​)
7.4.5 Diagnosed Cases (​​2019-2035​)
7.4.6 Patient Pool/Treated Cases (​​2019-2035​)
7.5 Epidemiology Scenario - France
7.5.1 Epidemiology Scenario (​2019-2024​)
7.5.2 Epidemiology Forecast (​2025-2035​)
7.5.3 Epidemiology by Age (​​2019-2035​)
7.5.4 Epidemiology by Gender (​​2019-2035​)
7.5.5 Diagnosed Cases (​​2019-2035​)
7.5.6 Patient Pool/Treated Cases (​​2019-2035​)
7.6 Epidemiology Scenario - United Kingdom
7.6.1 Epidemiology Scenario (​2019-2024​)
7.6.2 Epidemiology Forecast (​2025-2035​)
7.6.3 Epidemiology by Age (​​2019-2035​)
7.6.4 Epidemiology by Gender (​​2019-2035​)
7.6.5 Diagnosed Cases (​​2019-2035​)
7.6.6 Patient Pool/Treated Cases (​​2019-2035​)
7.7 Epidemiology Scenario - Italy
7.7.1 Epidemiology Scenario (​2019-2024​)
7.7.2 Epidemiology Forecast (​2025-2035​)
7.7.3 Epidemiology by Age (​​2019-2035​)
7.7.4 Epidemiology by Gender (​​2019-2035​)
7.7.5 Diagnosed Cases (​​2019-2035​)
7.7.6 Patient Pool/Treated Cases (​​2019-2035​)
7.8 Epidemiology Scenario - Spain
7.8.1 Epidemiology Scenario (​2019-2024​)
7.8.2 Epidemiology Forecast (​2025-2035​)
7.8.3 Epidemiology by Age (​​2019-2035​)
7.8.4 Epidemiology by Gender (​​2019-2035​)
7.8.5 Diagnosed Cases (​​2019-2035​)
7.8.6 Patient Pool/Treated Cases (​​2019-2035​)
7.9 Epidemiology Scenario - Japan
7.9.1 Epidemiology Scenario (​2019-2024​)
7.9.2 Epidemiology Forecast (​2025-2035​)
7.9.3 Epidemiology by Age (​​2019-2035​)
7.9.4 Epidemiology by Gender (​​2019-2035​)
7.9.5 Diagnosed Cases (​​2019-2035​)
7.9.6 Patient Pool/Treated Cases (​​2019-2035​)
8 Pompe Disease - Treatment Algorithm, Guidelines, and Medical Practices
8.1 Guidelines, Management and Treatment
8.2 Treatment Algorithm
9 Pompe Disease - Unmet Needs
10 Pompe Disease - Key Endpoints of Treatment
11 Pompe Disease - Marketed Products

11.1 List of Pompe Disease Marketed Drugs Across the Top 7 Markets
11.1.1    Nexviazyme (avalglucosidase alfa-ngpt) - Sanofi
11.1.1.1 Drug Overview
11.1.1.2 Mechanism of Action
11.1.1.3 Regulatory Status
11.1.1.4 Clinical Trial Results
11.1.1.5 Sales Across Major Markets
11.1.2    Myozyme (alglucosidase alfa)
11.1.2.1 Drug Overview
11.1.2.2 Mechanism of Action
11.1.2.3 Regulatory Status
11.1.2.4 Clinical Trial Results
11.1.2.5 Sales Across Major Markets

Kindly note that the above only represents a partial list of marketed drugs, and the complete list has been provided in the report.

12 Pompe Disease - Pipeline Drugs
12.1 List of Pompe Disease Pipeline Drugs Across the Top 7 Markets
12.1.1 ABX 1100-Aro Biotherapeutics
12.1.1.1 Drug Overview
12.1.1.2 Mechanism of Action
12.1.1.3 Clinical Trial Results
12.1.1.4 Safety and Efficacy
12.1.1.5 Regulatory Status
12.1.2 Imlifidase- Hansa Biopharma
12.1.2.1 Drug Overview
12.1.2.2 Mechanism of Action
12.1.2.3 Clinical Trial Results
12.1.2.4 Safety and Efficacy
12.1.2.5 Regulatory Status
12.1.3 DNL 952-Denali Therapeutics Inc
12.1.3.1 Drug Overview
12.1.3.2 Mechanism of Action
12.1.3.3 Clinical Trial Results
12.1.3.4 Safety and Efficacy
12.1.3.5 Regulatory Status

Kindly note that the above only represents a partial list of pipeline drugs, and the complete list has been provided in the report.

13. Pompe Disease - Attribute Analysis of Key Marketed and Pipeline Drugs
14. Pompe Disease – Clinical Trial Landscape

14.1 Drugs by Status
14.2 Drugs by Phase
14.3 Drugs by Route of Administration
14.4 Key Regulatory Events
15 Pompe Disease - Market Scenario
15.1 Market Scenario - Key Insights
15.2 Market Scenario - Top 7 Markets
15.2.1    Pompe Disease - Market Size
15.2.1.1 Market Size (​2019-2024​)
15.2.1.2 Market Forecast (​2025-2035​)
15.2.2    Pompe Disease - Market Size by Therapies
15.2.2.1 Market Size by Therapies (​2019-2024​)
15.2.2.2 Market Forecast by Therapies (​2025-2035​)
15.3 Market Scenario - United States
15.3.1    Pompe Disease - Market Size
15.3.1.1 Market Size (​2019-2024​)
15.3.1.2 Market Forecast (​2025-2035​)
15.3.2    Pompe Disease - Market Size by Therapies
15.3.2.1 Market Size by Therapies (​2019-2024​)
15.3.2.2 Market Forecast by Therapies (​2025-2035​)
15.3.3    Pompe Disease - Access and Reimbursement Overview
15.4 Market Scenario - Germany
15.4.1    Pompe Disease - Market Size
15.4.1.1 Market Size (​2019-2024​)
15.4.1.2 Market Forecast (​2025-2035​)
15.4.2    Pompe Disease - Market Size by Therapies
15.4.2.1 Market Size by Therapies (​2019-2024​)
15.4.2.2 Market Forecast by Therapies (​2025-2035​)
15.4.3    Pompe Disease - Access and Reimbursement Overview
15.5 Market Scenario - France
15.5.1    Pompe Disease - Market Size
15.5.1.1 Market Size (​2019-2024​)
15.5.1.2 Market Forecast (​2025-2035​)
15.5.2    Pompe Disease - Market Size by Therapies
15.5.2.1 Market Size by Therapies (​2019-2024​)
15.5.2.2 Market Forecast by Therapies (​2025-2035​)
15.5.3    Pompe Disease - Access and Reimbursement Overview
15.6 Market Scenario - United Kingdom
15.6.1    Pompe Disease - Market Size
15.6.1.1 Market Size (​2019-2024​)
15.6.1.2 Market Forecast (​2025-2035​)
15.6.2    Pompe Disease - Market Size by Therapies
15.6.2.1 Market Size by Therapies (​2019-2024​)
15.6.2.2 Market Forecast by Therapies (​2025-2035​)
15.6.3    Pompe Disease - Access and Reimbursement Overview
15.7 Market Scenario - Italy
15.7.1    Pompe Disease - Market Size
15.7.1.1 Market Size (​2019-2024​)
15.7.1.2 Market Forecast (​2025-2035​)
15.7.2    Pompe Disease - Market Size by Therapies
15.7.2.1 Market Size by Therapies (​2019-2024​)
15.7.2.2 Market Forecast by Therapies (​2025-2035​)
15.7.3    Pompe Disease - Access and Reimbursement Overview
15.8 Market Scenario - Spain
15.8.1    Pompe Disease - Market Size
15.8.1.1 Market Size (​2019-2024​)
15.8.1.2 Market Forecast (​2025-2035​)
15.8.2    Pompe Disease - Market Size by Therapies
15.8.2.1 Market Size by Therapies (​2019-2024​)
15.8.2.2 Market Forecast by Therapies (​2025-2035​)
15.8.3    Pompe Disease - Access and Reimbursement Overview
15.9   Market Scenario - Japan
15.9.1    Pompe Disease - Market Size
15.9.1.1 Market Size (​2019-2024​)
15.9.1.2 Market Forecast (​2025-2035​)
15.9.2    Pompe Disease - Market Size by Therapies
15.9.2.1 Market Size by Therapies (​2019-2024​)
15.9.2.2 Market Forecast by Therapies (​2025-2035​)
15.9.3    Pompe Disease - Access and Reimbursement Overview
16 Pompe Disease - Recent Events and Inputs from Key Opinion Leaders
17 Pompe Disease Market - SWOT Analysis

17.1 Strengths
17.2 Weaknesses
17.3 Opportunities
17.4 Threats  
18 Pompe Disease Market – Strategic Recommendations
19 Appendix

Pompe Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2035
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials